Anti-tumor activity of oxypeucedanin from Ostericum koreanum against human prostate carcinoma DU145 cells

References

• Wall ME, Wani MC, Manikumar G., Hughes TJ, Taylor H, McGivney R, et al. Plant antimutagenic agents, 3. Coumarins. J Nat Prod 1988; 51: 1148–52
   PubMed Web of Science ®Google Scholar
• Cai Y, Baer-Dubowska W, Ashwood-Smith M, DiGiovanni J. Inhibitory effects of naturally occurring coumarins on the metabolic activation of benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene in cultured mouse keratinocytes. Carcinogenesis 1997; 18: 215–22
   PubMed Web of Science ®Google Scholar
• Chi HJ, Kim HS. Pharmacological study of isoimperatorin and oxypeucedanin. Kor J Pharmac 1970; 14: 21–7
   Google Scholar
• Oh H, Lee HS, Kim TW, Chai KY, Chung HT, Kwon TO, et al. Furocoumarins from Angelica dahurica with hepatoprotective activity on tacrine-induced cytotoxicity in Hep G2 cells. Planta Med 2002; 68: 463–4
   PubMed Web of Science ®Google Scholar
• Kang JY, Lee SY, Yim DS. Effect of isoimperatorin on the proliferation of prostate cancer cell line du145 cells. J Appl Pharmacol 2005; 13: 185–9
   Google Scholar
• Denmeade SR, Isaacs JT. A history of prostate cancer treatment. Nat Rev Cancer 2002; 2: 389–96
   PubMed Web of Science ®Google Scholar
• Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, et al. Cancer statistics, 2005. CA Cancer J Clin 2005; 55: 10–30
   PubMed Web of Science ®Google Scholar
• Nelson WG., De Marzo AM, Deweese TL, Lin X, Brooks JD, Putzi MJ, et al. Preneoplastic prostate lesions: An opportunity for prostate cancer prevention. Ann NY Acad Sci 2001; 952: 135–44
   PubMed Web of Science ®Google Scholar
• De Marzo AM, Meeker AK, Zha S, Luo J, Nakayama M, Platz EA, et al. Human prostate cancer precursors and pathobiology. Urology 2003; 62: 55–62
   PubMed Web of Science ®Google Scholar
• Godley PA, Campbell MK, Gallagher P, Martinson FEA, Mohler JL, Sandler RS. Biomarkers of essential fatty acid consumption and risk of prostatic carcinoma. Cancer Epidemol Biomark Prev 1996; 5: 889–95
   PubMed Web of Science ®Google Scholar
• Ross RK, Henderson BE. Do diet and androgens alter prostate cancer risk via a common etiologic pathway?. J Natl Cancer Inst 1994; 86: 252–4
   PubMed Web of Science ®Google Scholar
• Baek NI, Ahn Em, Kim HY, Park YD. Furanocoumarins from the root of Angelica dahurica. Arch Pharm Res 2000; 23: 467–70
   PubMed Web of Science ®Google Scholar
• Tyagi A, Bhatia N, Condon MS, Bosland MC, Agarwal C, Agarwal R. Antiproliferative and apoptotic effects of silibinin in rat prostate cancer cells. Prostate 2002; 53: 211–7
   PubMed Web of Science ®Google Scholar
• Singh RP, Agrawal P, Yim D, Agarwal C, Agarwal R. Acacetin inhibits cell growth and cell cycle progression and induces apoptosis in human prostate cancer cells. Structure-activity relationship with linarin and linarin acetate Carcinogenesis 2005; 26: 845–54
   Google Scholar
• Grana X, Reddy EP. Cell cycle control in mammalian cells: Role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene 1995; 11: 211–9
   PubMed Web of Science ®Google Scholar
• Singh RP, Dhanalakshmi S, Agarwal R. Phytochemicals as cell cycle modulators–a less toxic approach in halting human cancers. Cell Cycle 2002; 1: 156–61
   PubMed Web of Science ®Google Scholar
• Lowe SW, Lin AW. Apoptosis in cancer. Carcinogenesis 2000; 21: 485–95
   PubMed Web of Science ®Google Scholar
• Lee YY, Lee S, Jin JL, Yun-Choi HS. Platelet anti-aggregatory effects of coumarins from the roots of Angelica genuflexa and A. gigas. Arch Pharm Res 2003; 26: 723–6
   PubMed Web of Science ®Google Scholar
• Kim YK, Kim YS, Ryu SY. Antiproliferative effect of furanocoumarins from the root of Angelica dahurica on cultured human tumor cell lines. Phytother Res 2007; 21: 288–90
   PubMed Web of Science ®Google Scholar
• Kim CM, Heo MY, Kim HP, Sin KS, Pachaly P. Pharmacological activities of water extracts of Umbelliferae plants. Arch Pharm Res 1991; 14: 87–92
   PubMedGoogle Scholar
• Yuan J, Yan R, Kramer A, Eckerdt F, Roller M, Kaufmann M, et al. Cyclin B1 depletion inhibits proliferation and induces apoptosis in human tumor cells. Oncogene 2004; 23: 5843–52
   PubMed Web of Science ®Google Scholar
• Graves PR, Yu L, Schwarz JK, Gales J, Sausville EA, O'Connor PM, et al. The Chk1 protein kinase and the Cdc25C regulatory pathways are targets of the anticancer agent UCN-01. J Biol Chem 2000; 275: 5600–5
   PubMed Web of Science ®Google Scholar
• Gurumurthy S, Vasudevan KM, Rangnekar VM. Regulation of apoptosis in prostate cancer. Cancer Metastasis Rev 2001; 20: 225–43
   PubMed Web of Science ®Google Scholar
• Pilat MJ, Kamradt JM, Pienta KJ. Hormone resistance in prostate cancer. Cancer Metastasis 1998–1999; 17: 373–81
   PubMed Web of Science ®Google Scholar
• Kantoff PW. New agents in the therapy of hormone-refractory patients with prostate cancer. Semin Oncol 1995; 22: 32–4
   PubMed Web of Science ®Google Scholar